enVVeno Medical (NVNO) Current Leases (2019 - 2026)
enVVeno Medical's (NVNO) quarterly Current Leases came in at $396000.0 in Q1 2026, up 7.03% year-on-year from $370000.0 in Q1 2025, and up 1.54% quarter-over-quarter from $390000.0 in Q4 2025.
enVVeno Medical (NVNO) Current Leases (2019 - 2026) Analysis & Trends
enVVeno Medical's Current Leases history runs 8 years deep, the most recent figure standing at $396000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 7.03% year-over-year to $396000.0 in Q1 2026; TTM through Mar 2026 was $396000.0, a 7.03% increase from a year earlier, with the FY2025 full-year figure at $390000.0, up 7.14% from the prior year.
- Current Leases improved to $396000.0 in Q1 2026 per NVNO's latest filing, from $390000.0 in the prior quarter.
- Across five years, Current Leases topped out at $396000.0 in Q1 2026 and bottomed at $286000.0 in Q3 2025.
- The 5-year median for Current Leases is $344000.0 (2024), against an average of $341058.8.
- Across the five-year window, Current Leases rose 16.17% in 2023 and retreated 19.89% in 2025, its largest moves.
- Year by year, Current Leases stood at $314000.0 in 2022, then climbed by 7.64% to $338000.0 in 2023, then gained by 7.69% to $364000.0 in 2024, then rose by 7.14% to $390000.0 in 2025, then gained by 1.54% to $396000.0 in 2026.
- Per Business Quant, the three latest NVNO Current Leases figures stand at $396000.0 (Q1 2026), $390000.0 (Q4 2025), and $286000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 20.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - | 396,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 396,000.00 |
| Dec 31, 2025 | 390,000.00 |
| Sep 30, 2025 | 286,000.00 |
| Jun 30, 2025 | 377,000.00 |
| Mar 31, 2025 | 370,000.00 |
| Dec 31, 2024 | 364,000.00 |
| Sep 30, 2024 | 357,000.00 |
| Jun 30, 2024 | 351,000.00 |
| Mar 31, 2024 | 344,000.00 |
| Dec 31, 2023 | 338,000.00 |
| Sep 30, 2023 | 331,000.00 |
| Jun 30, 2023 | 352,000.00 |
| Mar 31, 2023 | 320,000.00 |
| Dec 31, 2022 | 314,000.00 |
| Sep 30, 2022 | 308,000.00 |
| Jun 30, 2022 | 303,000.00 |
| Mar 31, 2022 | 297,000.00 |
| Dec 31, 2021 | 291,000.00 |
| Sep 30, 2021 | 332,297.00 |
| Jun 30, 2021 | 326,265.00 |